202 related articles for article (PubMed ID: 31142363)
1. Prediction of hepatocellular carcinoma response to
Gordic S; Wagner M; Zanato R; Hectors S; Besa C; Kihira S; Kim E; Taouli B
Cancer Imaging; 2019 May; 19(1):29. PubMed ID: 31142363
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.
Kokabi N; Camacho JC; Xing M; Qiu D; Kitajima H; Mittal PK; Kim HS
Abdom Imaging; 2014 Oct; 39(5):969-78. PubMed ID: 24740759
[TBL] [Abstract][Full Text] [Related]
3. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
4. Response Assessment by Volumetric Iodine Uptake Measurement: Preliminary Experience in Patients with Intermediate-Advanced Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization.
Bargellini I; Crocetti L; Turini FM; Lorenzoni G; Boni G; Traino AC; Caramella D; Cioni R
Cardiovasc Intervent Radiol; 2018 Sep; 41(9):1373-1383. PubMed ID: 29654507
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Hepatocellular Carcinoma Response to
Hectors SJ; Lewis S; Kennedy P; Bane O; Said D; Segall M; Schwartz M; Kim E; Taouli B
Radiol Imaging Cancer; 2020 Jul; 2(4):e190094. PubMed ID: 32803165
[TBL] [Abstract][Full Text] [Related]
6. Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?
Vouche M; Salem R; Lewandowski RJ; Miller FH
Abdom Imaging; 2015 Aug; 40(6):1471-80. PubMed ID: 25412868
[TBL] [Abstract][Full Text] [Related]
7. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725
[TBL] [Abstract][Full Text] [Related]
8. Early effect of
Kennedy P; Lewis S; Bane O; Hectors SJ; Kim E; Schwartz M; Taouli B
Eur Radiol; 2021 Aug; 31(8):5791-5801. PubMed ID: 33475773
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
10. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers.
Lewis S; Peti S; Hectors SJ; King M; Rosen A; Kamath A; Putra J; Thung S; Taouli B
Abdom Radiol (NY); 2019 Mar; 44(3):912-922. PubMed ID: 30712136
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Hepatocellular Carcinoma Response After
Semaan S; Makkar J; Lewis S; Chatterji M; Kim E; Taouli B
AJR Am J Roentgenol; 2017 Nov; 209(5):W263-W276. PubMed ID: 29072955
[TBL] [Abstract][Full Text] [Related]
13. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
Sabet A; Ahmadzadehfar H; Bruhman J; Sabet A; Meyer C; Wasmuth JC; Pieper CC; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(2):39-45. PubMed ID: 24777354
[TBL] [Abstract][Full Text] [Related]
14. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
[TBL] [Abstract][Full Text] [Related]
15. MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques.
Galizia MS; Töre HG; Chalian H; McCarthy R; Salem R; Yaghmai V
Acad Radiol; 2012 Jan; 19(1):48-54. PubMed ID: 22054801
[TBL] [Abstract][Full Text] [Related]
16. Role of baseline volumetric functional MRI in predicting histopathologic grade and patients' survival in hepatocellular carcinoma.
Ameli S; Shaghaghi M; Aliyari Ghasabeh M; Pandey P; Hazhirkarzar B; Ghadimi M; Rezvani Habibabadi R; Khoshpouri P; Pandey A; Anders RA; Kamel IR
Eur Radiol; 2020 Jul; 30(7):3748-3758. PubMed ID: 32144459
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ADC measurements in predicting overall survival in patients undergoing
Alis D; Durmaz ESM; Gulsen F; Bas A; Kabasakal L; Sager S; Numan F
Clin Imaging; 2019; 57():124-130. PubMed ID: 31220677
[TBL] [Abstract][Full Text] [Related]
18. Does the change in volumetric functional MR metrics post-TACE predict histopathologic grading of hepatocellular carcinoma?
Ameli S; Shaghaghi M; Ghasabeh MA; Pandey P; Hazhirkarzar B; Habibabadi RR; Ghadimi M; Khoshpouri P; Pandey A; Kamel IR
Eur Radiol; 2020 Dec; 30(12):6709-6720. PubMed ID: 32671512
[TBL] [Abstract][Full Text] [Related]
19. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H
J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751
[TBL] [Abstract][Full Text] [Related]
20. Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology.
Vietti Violi N; Gnerre J; Law A; Hectors S; Bane O; Doucette J; Abboud G; Kim E; Schwartz M; Fiel MI; Taouli B
Eur Radiol; 2022 Sep; 32(9):6493-6503. PubMed ID: 35380226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
